Acquiring Company
Yarrow Bioscience
Acquired Company
Yarrow Bioscience
New HavenNew HavenBiotechnologyHealthcareHealth CareTherapeuticsBiotechnologyHealthcareHealth CareTherapeuticsDescription
Yarrow Bioscience has successfully completed its merger with VYNE Therapeutics. Following the merger, the combined entity will continue under the Yarrow Bioscience name and will initiate dosing in a Phase 2a/2b trial for YB-101. The merger included private financings totaling approximately $200 million.
Who to call at Yarrow Bioscience, and when
When Yarrow Bioscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Yarrow Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Yarrow Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Yarrow Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Yarrow Bioscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Yarrow Bioscience?
Yarrow Bioscience was acquired by Yarrow Bioscience, based in New Haven. The deal was reported on July 27, 2026. Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Yarrow Bioscience is publicly traded (YARW) and operates in Biotechnology.
When did Yarrow Bioscience acquire Yarrow Bioscience?
Yarrow Bioscience's acquisition of Yarrow Bioscience was reported on July 27, 2026. Yarrow Bioscience has successfully completed its merger with VYNE Therapeutics. Following the merger, the combined entity will continue under the Yarrow Bioscience name and will initiate dosing in a Phase 2a/2b trial for YB-101. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Yarrow Bioscience do?
Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. It is publicly traded (YARW), operating in Biotechnology, and is based in New Haven.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.